crisprScienceThis Gene-Editing Tech Might Be Too Dangerous To UnleashBy Megan MolteniScienceCrispr Fans Dream of a Populist Future for Gene EditingBy Megan MolteniScienceUS Scientists Edit an Embryo—But Superbabies Won’t Come EasyBy Megan MolteniScienceScientists Crispr the First Human Embryos in the US (Maybe)By Megan MolteniScienceScientists Upload a Horse GIF Into Bacteria With CrisprBy Megan MolteniScienceCrispr's Next Big Debate: How Messy Is Too Messy?By Megan MolteniScienceCrispr Creator Jennifer Doudna on the Promises—and Pitfalls—of Easy Genetic ModificationBy Anna VlasitsBusinessAndy Rubin, Crispr, and Amazon Star at WIRED Business Conference 2017By WIRED StaffOpinionCrispr Makes It Clear: The US Needs a Biology Strategy, and FastBy Amy WebbScienceHow Crispr Could Snip Away Some of Humanity's Worst DiseasesBy Nick StocktonScienceWho Wants Disease-Resistant GM Tomatoes? Probably Not EuropeBy Adam RogersScienceMIT’s Crispr Guy Braves Enemy Territory at UC BerkeleyBy Anna VlasitsScienceHuman Embryo Editing Gets the OK—But No SuperbabiesBy Eric NiilerScienceFrom Crispr to Zika, Here Are 2016's Biggest Biology StoriesBy Chelsea LeuScienceBlood Diseases Could Show Crispr's Potential as TherapyBy Nikhil SwaminathanScienceGenetic Architects Untwist DNA’s Turns With CrisprBy Carrie ArnoldScienceHey, J.Lo: We Wrote Your Gene-Hacking Drama for YouBy Nick StocktonScienceYou Can Soon Grow Human-Animal Hybrids, But You Can't Breed ‘EmBy Eric NiilerScienceSave the Galapagos With GMO Rats. What Could Go Wrong?By Sarah ZhangScienceCan You Tell These Real Crispr Projects From the Fake Ones?By Sarah ZhangScienceCrispr Gene-Editing Upstart Editas Goes Public as Patent Battle RagesBy Julia GreenbergScienceInternet Outrage Is Shaping the Battle Over CrisprBy Sarah ZhangScienceScientists Capture Crispr's Gene-Cutting in ActionBy Sarah ZhangScienceAn Arcane Patent Law May Decide Crispr's Big Legal FightBy Sarah ZhangMore Stories
